Company Filing History:
Years Active: 1996-1999
Title: Shoshana Eitan: Innovator in Neuropharmaceuticals
Introduction
Shoshana Eitan is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of neuropharmaceuticals, particularly in the regeneration of injured nerves in the central nervous system. With a total of 3 patents, her work is paving the way for innovative treatments in this critical area of medicine.
Latest Patents
Eitan's latest patents include groundbreaking inventions that focus on enhancing nerve regeneration. One of her notable patents is the "Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 factor." This invention describes an enzymatically-producible dimeric IL-2, specifically human dimeric IL-2, which exhibits oligodendrocyte cytotoxic activity. This compound is useful as an active ingredient in pharmaceutical compositions aimed at inducing and facilitating the regeneration of injured nerves in mammals, including humans.
Another significant patent is the "Nerve-derived transglutaminase enzyme." This invention introduces a new nerve-derived transglutaminase enzyme that converts immune-derived IL-2 into dimeric IL-2 with oligodendrocyte cytotoxic activity. Both the nerve-derived transglutaminase and the dimeric mammalian IL-2 are intended for use as active ingredients in pharmaceutical compositions for nerve regeneration.
Career Highlights
Shoshana Eitan is associated with Yeda Research and Development Co. Ltd., where she continues to advance her research and innovations. Her work is characterized by a strong focus on the intersection of immunology and neurobiology, leading to promising developments in therapeutic applications.
Collaborations
Eitan collaborates with esteemed colleagues, including Michal Eisenbach-Schwartz and Michal Schwartz. Their combined expertise enhances the research efforts and contributes to the success of their projects.
Conclusion
Shoshana Eitan's innovative work in neuropharmaceuticals is making a significant impact on the field of nerve regeneration. Her patents reflect a commitment to advancing medical science and improving treatment options for patients with nerve injuries.